BARACLUDE Side Effects

6832071-7 | Hyperlactacidaemia, Nephrotic Syndrome, Renal Impairment
on Jul 07, 2010 Male patient from JAPAN , 51 years of age, weighting 185.2 lb, was diagnosed with hepatitis b (What is hepatitis b?), ascites, varices oesophageal, hyperammonaemia and was treated with Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: hyperlactacidaemia, nephrotic syndrome, renal impairment. Baraclude dosage: 1mg/d(07may07-20apr09);0.5mg/d(21apr09-ong).. During the same period patient was treated with ADEFOVIR DIPIVOXIL KIT (Formulation : Tablet.) (View Adefovir Dipivoxil Kit Review and Adefovir Dipivoxil Kit Label ), LASIX (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), OMEPRAL (Formulation : Tablet.) (View Omepral Review and Omepral Label ), AMINOLEBAN (Aminoleban En (enteral Nutrient For Hepatic Failure).) (View Aminoleban Review and Aminoleban Label ). Patient was hospitalized.

6831237-X | Hiv Infection, Viral Mutation Identified
Patient was taking Baraclude (View Usage). Patient had the following side effects: hiv infection (What is hiv infection?), viral mutation identified on Jul 06, 2010 from UNITED STATES Additional patient health information: Male patient , 46 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and. Baraclude dosage: .

6826354-4 | Oesophageal Varices Haemorrhage, Pneumonia Aspiration, Septic Shock
Adverse event was reported on Jul 05, 2010 by a Male patient taking Baraclude (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: ITALY , 59 years of age, After Baraclude was administered, patient had the following side effects: oesophageal varices haemorrhage, pneumonia aspiration, septic shock. Patient was hospitalized.

6826206-X | Blood Chloride Decreased, Blood Creatine Phosphokinase Mb Increased, Blood Sodium Decreased, Hypoaesthesia, Hyponatraemia, Myalgia
on Jul 05, 2010 Male patient from CHINA , 50 years of age, was diagnosed with hepatitis b (What is hepatitis b?), hepatic cirrhosis and was treated with Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: blood chloride decreased, blood creatine phosphokinase mb increased, blood sodium decreased, hypoaesthesia, hyponatraemia, myalgia. Baraclude dosage: . During the same period patient was treated with ESSENTIALE (View Essentiale Review and Essentiale Label ).


6820535-1 | Haemolytic Anaemia, Pyrexia
on Jun 30, 2010 Male patient from FRANCE , 26 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). Patient had the following side effects: haemolytic anaemia, pyrexia. Baraclude dosage: .

6817875-9 | Leukopenia, Thrombocytopenia
Patient was taking Baraclude (View Usage). After Baraclude was administered, patient had the following side effects: leukopenia, thrombocytopenia on Jul 02, 2010 from GREECE Additional patient health information: Male patient , 75 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and. Baraclude dosage: . During the same period patient was treated with SALOSPIR (View Salospir Review and Salospir Label ), SOLOSA (View Solosa Review and Solosa Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6817871-1 | Erythema Multiforme, Pemphigoid
Adverse event was reported on Jun 29, 2010 by a Female patient taking Baraclude (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?), rash (What is rash?), liver disorder and. Location: JAPAN , 71 years of age, weighting 121.3 lb, Patient experienced the following unwanted or unexpected effects: erythema multiforme, pemphigoid. During the same period patient was treated with ONEALFA (View Onealfa Review and Onealfa Label ), ZEFIX (Tabs) (View Zefix Review and Zefix Label ), CALCIUM ASPARTATE (Tablet) (View Calcium Aspartate Review and Calcium Aspartate Label ), POTASSIUM ASPARTATE (View Potassium Aspartate Review and Potassium Aspartate Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ). Patient was hospitalized.

6816207-X | Enterocolitis Infectious, Oesophageal Candidiasis, Vasculitis
on Jun 30, 2010 Male patient from TAIWAN, PROVINCE OF CHINA , 31 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). Patient had the following side effects: enterocolitis infectious, oesophageal candidiasis, vasculitis (What is vasculitis?). Baraclude dosage: .

6814411-8 | Hyperlactacidaemia, Nephrotic Syndrome, Renal Impairment
on Jun 24, 2010 Male patient from JAPAN , 51 years of age, weighting 185.2 lb, was diagnosed with hepatitis b (What is hepatitis b?), ascites, varices oesophageal, amino acid level decreased and was treated with Baraclude (View Usage). After Baraclude was administered, patient had the following side effects: hyperlactacidaemia, nephrotic syndrome, renal impairment. Baraclude dosage: 1mg/d(07may07-20apr09);0.5mg/d(21apr09-ong).. During the same period patient was treated with ADEFOVIR DIPIVOXIL (Formulation : Tablet.) (View Adefovir Dipivoxil Review and Adefovir Dipivoxil Label ), LASIX (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), OMEPRAL (Formulation : Tablet.) (View Omepral Review and Omepral Label ), AMINOLEBAN (Aminoleban En (enteral Nutrient For Hepatic Failure).) (View Aminoleban Review and Aminoleban Label ). Patient was hospitalized.

6810290-3 | Abdominal Pain Upper, Hepatic Cirrhosis, Rash
Patient was taking Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, hepatic cirrhosis, rash (What is rash?) on Jun 24, 2010 from CHINA Additional patient health information: Male patient , 32 years of age, . Baraclude dosage: .

6803659-4 | Abdominal Pain Upper, Back Pain, Dyspnoea, Fatigue, Feeling Jittery, Mucous Stools, Musculoskeletal Chest Pain
Adverse event was reported on Jun 16, 2010 by a Male patient taking Baraclude (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: INDIA , 48 years of age, Patient had the following side effects: abdominal pain upper, back pain (What is back pain?), dyspnoea, fatigue, feeling jittery, mucous stools, musculoskeletal chest pain.

6802751-8 | Anaemia, Duodenal Ulcer
on Jun 21, 2010 Female patient from JAPAN , 54 years of age, was diagnosed with hepatitis b (What is hepatitis b?), hypertension and was treated with Baraclude (View Usage). After Baraclude was administered, patient had the following side effects: anaemia, duodenal ulcer. Baraclude dosage: . During the same period patient was treated with AMLODIN (31mar08 Form:tabs) (View Amlodin Review and Amlodin Label ).

6791075-3 | Hepatitis B Dna Increased
on Jun 11, 2010 Male patient from AUSTRALIA , 42 years of age, was treated with Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis b dna increased. Baraclude dosage: . During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), TRUVADA (View Truvada Review and Truvada Label ).

6790277-X | Hepatic Neoplasm Malignant
Patient was taking Baraclude (View Usage). Patient had the following side effects: hepatic neoplasm malignant on Jun 21, 2010 from BRAZIL Additional patient health information: Male patient , 55 years of age, . Baraclude dosage: .

6784523-6 | Erythema, Rash Pruritic, Skin Lesion
Adverse event was reported on Jun 18, 2010 by a Male patient taking Baraclude (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: TURKEY , 33 years of age, weighting 231.5 lb, After Baraclude was administered, patient had the following side effects: erythema, rash pruritic, skin lesion.

6782882-1 | Leukopenia, Thrombocytopenia
on Jun 17, 2010 Male patient from GREECE , 75 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: leukopenia, thrombocytopenia. Baraclude dosage: . During the same period patient was treated with SALOSPIR (View Salospir Review and Salospir Label ), SOLOSA (View Solosa Review and Solosa Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6782879-1 | Abortion Induced, Pregnancy
on Jun 16, 2010 Female patient from UNITED STATES , 25 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). Patient had the following side effects: abortion induced, pregnancy (What is pregnancy?). Baraclude dosage: .

6779977-5 | Somnolence, Suicide Attempt
Patient was taking Baraclude (View Usage). After Baraclude was administered, patient had the following side effects: somnolence, suicide attempt on Jun 14, 2010 from GERMANY Additional patient health information: Female patient , 19 years of age, weighting 143.3 lb, . Baraclude dosage: Totally 15 Tabs, Intake Not Assured. During the same period patient was treated with SEROQUEL (Totally= 10 Tabs;intake Not Assured) (View Seroquel Review and Seroquel Label ).

6771338-8 | Atrioventricular Block Complete
Adverse event was reported on Jun 08, 2010 by a Male patient taking Baraclude (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: JAPAN , 73 years of age, Patient experienced the following unwanted or unexpected effects: atrioventricular block complete. During the same period patient was treated with URINORM (View Urinorm Review and Urinorm Label ), CONIEL (View Coniel Review and Coniel Label ). Patient was hospitalized.

6766610-1 | Blood Creatine Phosphokinase Mb Increased, Hypoaesthesia, Myalgia
on Jun 08, 2010 Male patient from CHINA , 50 years of age, was diagnosed with hepatitis b (What is hepatitis b?), hepatic cirrhosis and was treated with Baraclude (View Usage). Patient had the following side effects: blood creatine phosphokinase mb increased, hypoaesthesia, myalgia. Baraclude dosage: . During the same period patient was treated with ESSENTIALE (View Essentiale Review and Essentiale Label ).

6757901-9 | Abortion Induced, Pregnancy
on Jun 03, 2010 Female patient from RUSSIAN FEDERATION , 25 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). After Baraclude was administered, patient had the following side effects: abortion induced, pregnancy (What is pregnancy?). Baraclude dosage: .

6747567-6 | Somnolence, Suicide Attempt
Patient was taking Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: somnolence, suicide attempt on May 21, 2010 from GERMANY Additional patient health information: Female patient , 19 years of age, . Baraclude dosage: Totally 15 Tabs, Intake Not Assured. During the same period patient was treated with SEROQUEL (Totally= 10 Tabs;intake Not Assured) (View Seroquel Review and Seroquel Label ).

6747540-8 | White Blood Cell Count Decreased
Adverse event was reported on May 20, 2010 by a Female patient taking Baraclude (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: JAPAN , 61 years of age, Patient had the following side effects: white blood cell count decreased. During the same period patient was treated with COTRIM (View Cotrim Review and Cotrim Label ). Patient was hospitalized.

6732700-2 | Alopecia, Dry Eye, Eye Pain
on Mar 18, 2010 Female patient from UNITED STATES , 66 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). After Baraclude was administered, patient had the following side effects: alopecia, dry eye, eye pain. Baraclude dosage: Past Treated For 1 Year And Discont. During the same period patient was treated with TENOFOVIR (View Tenofovir Review and Tenofovir Label ).

6732696-3 | Blood Bilirubin Increased
on Mar 03, 2010 Male patient from UNITED STATES , 70 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin increased. Baraclude dosage: . During the same period patient was treated with COLESTID (View Colestid Review and Colestid Label ), JANUVIA (View Januvia Review and Januvia Label ), LOTREL (View Lotrel Review and Lotrel Label ), COUMADIN (View Coumadin Review and Coumadin Label ).

6732693-8 | Stomatitis
Patient was taking Baraclude (View Usage). Patient had the following side effects: stomatitis on Feb 02, 2010 from UNITED STATES Additional patient health information: Male patient , 51 years of age, weighting 180.8 lb, was diagnosed with hepatitis (What is hepatitis?) and. Baraclude dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), NEXIUM (View Nexium Review and Nexium Label ), INDERAL (View Inderal Review and Inderal Label ), REGLAN (View Reglan Review and Reglan Label ).

6732689-6 | Neck Pain
Adverse event was reported on Dec 23, 2009 by a Male patient taking Baraclude (View Usage) (Dosage: Started On 05dec09 At A Dose Of 0.5mg/d And 1mg From 22dec09) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: UNITED STATES , 73 years of age, weighting 143.3 lb, After Baraclude was administered, patient had the following side effects: neck pain. During the same period patient was treated with DALMANE (View Dalmane Review and Dalmane Label ), PREVACID (View Prevacid Review and Prevacid Label ).

6732686-0 | Fatigue, Headache, Liver Injury
on Oct 27, 2009 Male patient from UNITED STATES , 55 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue, headache (What is headache?), liver injury. Baraclude dosage: Initiated At 0.5mg Qd. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), SINGULAIR (View Singulair Review and Singulair Label ), ZOLOFT (View Zoloft Review and Zoloft Label ).

6732683-5 | Dizziness, Fatigue, Feeling Cold, Headache, Hyperhidrosis, Palpitations, Tremor
on Nov 12, 2009 Male patient from UNITED STATES , 62 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). Patient had the following side effects: dizziness (What is dizziness?), fatigue, feeling cold, headache (What is headache?), hyperhidrosis, palpitations, tremor. Baraclude dosage: For 3 Months 1189863a3.

6732680-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
Patient was taking Baraclude (View Usage). After Baraclude was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased on Sep 18, 2009 from UNITED STATES Additional patient health information: Male patient , 50 years of age, weighting 198.4 lb, was diagnosed with hepatitis b (What is hepatitis b?) and. Baraclude dosage: . During the same period patient was treated with VICODIN ES (View Vicodin Es Review and Vicodin Es Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6732675-6 | Presyncope
Adverse event was reported on Nov 19, 2009 by a Male patient taking Baraclude (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: UNITED STATES , 48 years of age, Patient experienced the following unwanted or unexpected effects: presyncope.

6732674-4 | Fatigue, Nausea, Somnolence
on Aug 06, 2009 Male patient from UNITED STATES , 41 years of age, weighting 165.3 lb, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). Patient had the following side effects: fatigue, nausea (What is nausea?), somnolence. Baraclude dosage: . During the same period patient was treated with ULTRASE MT20 (View Ultrase Mt20 Review and Ultrase Mt20 Label ).

6732673-2 | Nausea, Palpitations
on Aug 06, 2009 Female patient from UNITED STATES , 35 years of age, weighting 110.2 lb, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). After Baraclude was administered, patient had the following side effects: nausea (What is nausea?), palpitations. Baraclude dosage: . During the same period patient was treated with ULTRASE MT20 (View Ultrase Mt20 Review and Ultrase Mt20 Label ).

6732672-0 | Abdominal Pain Upper, Dizziness, Nausea
Patient was taking Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, dizziness (What is dizziness?), nausea (What is nausea?) on Aug 06, 2009 from UNITED STATES Additional patient health information: Male patient , 47 years of age, weighting 198.4 lb, was diagnosed with hepatitis b (What is hepatitis b?) and. Baraclude dosage: . During the same period patient was treated with ULTRASE MT20 (View Ultrase Mt20 Review and Ultrase Mt20 Label ).

6732668-9 | Hepatitis B Dna Increased
Adverse event was reported on Aug 05, 2009 by a Male patient taking Baraclude (View Usage) (Dosage: ) . Location: UNITED STATES , 28 years of age, Patient had the following side effects: hepatitis b dna increased. During the same period patient was treated with VIREAD (View Viread Review and Viread Label ).

6732666-5 | Back Pain, Fatigue, Hypoaesthesia, Renal Disorder
on May 04, 2009 Male patient from UNITED STATES , 43 years of age, weighting 134.5 lb, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). After Baraclude was administered, patient had the following side effects: back pain (What is back pain?), fatigue, hypoaesthesia, renal disorder. Baraclude dosage: .

6732661-6 | Fatigue, White Blood Cell Count Decreased
on Apr 09, 2009 Female patient from UNITED STATES , 34 years of age, weighting 105.8 lb, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue, white blood cell count decreased. Baraclude dosage: .

6732659-8 | Normal Newborn, Pregnancy
Patient was taking Baraclude (View Usage). Patient had the following side effects: normal newborn, pregnancy (What is pregnancy?) on Feb 04, 2010 from UNITED STATES Additional patient health information: Female patient , 27 years of age, weighting 138.9 lb, was diagnosed with hepatitis b (What is hepatitis b?) and. Baraclude dosage: .

6732069-3 | Abortion Induced, Pregnancy
Adverse event was reported on May 14, 2010 by a Female patient taking Baraclude (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: JAPAN , 37 years of age, After Baraclude was administered, patient had the following side effects: abortion induced, pregnancy (What is pregnancy?).

6725333-5 | Retinal Vascular Occlusion
on May 11, 2010 Female patient from JAPAN , 58 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: retinal vascular occlusion. Baraclude dosage: . During the same period patient was treated with ANTICONVULSANT (View Anticonvulsant Review and Anticonvulsant Label ).

6725312-8 | Alanine Aminotransferase Increased, International Normalised Ratio Increased, Prothrombin Time Prolonged
on May 12, 2010 Male patient from BRAZIL , 39 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). Patient had the following side effects: alanine aminotransferase increased, international normalised ratio increased, prothrombin time prolonged. Baraclude dosage: .

6721410-3 | Lactic Acidosis, Virologic Failure
Patient was taking Baraclude (View Usage). After Baraclude was administered, patient had the following side effects: lactic acidosis, virologic failure on May 07, 2010 from UNITED STATES Additional patient health information: Female patient , 20 years of age, . Baraclude dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ).

6721409-7 | Lactic Acidosis
Adverse event was reported on May 07, 2010 by a Male patient taking Baraclude (View Usage) (Dosage: ) . Location: UNITED STATES , 70 years of age, Patient experienced the following unwanted or unexpected effects: lactic acidosis. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ). Patient was hospitalized.

6717986-2 | Platelet Count Decreased
on May 06, 2010 Male patient from CHINA , 50 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). Patient had the following side effects: platelet count decreased. Baraclude dosage: Dosage Decreased To 0.5mg/qd In Feb10.. Patient was hospitalized.

6711280-1 | Osteonecrosis
on Apr 29, 2010 Female patient from FRANCE , 40 years of age, was treated with Baraclude (View Usage). After Baraclude was administered, patient had the following side effects: osteonecrosis (What is osteonecrosis?). Baraclude dosage: . During the same period patient was treated with CORTICOSTEROID (View Corticosteroid Review and Corticosteroid Label ).

6711265-5 | Hepatic Neoplasm Malignant
Patient was taking Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic neoplasm malignant on Apr 29, 2010 from BRAZIL Additional patient health information: Male patient , 55 years of age, . Baraclude dosage: .

6710769-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hyperlactacidaemia
Adverse event was reported on Apr 26, 2010 by a Male patient taking Baraclude (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: ITALY , 56 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hyperlactacidaemia.

6710156-3 | Acute Hepatic Failure, Septic Shock
on Apr 29, 2010 Male patient from GERMANY , 63 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). After Baraclude was administered, patient had the following side effects: acute hepatic failure, septic shock. Baraclude dosage: .

6707126-8 | Lactic Acidosis
on Apr 29, 2010 Male patient from GERMANY , 57 years of age, weighting 143.3 lb, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Baraclude (View Usage). Patient experienced the following unwanted or unexpected effects: lactic acidosis. Baraclude dosage: . During the same period patient was treated with SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), CELLCEPT (1 Df=500 Units Not Specified) (View Cellcept Review and Cellcept Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), OMEPRAZOLE (1 Df=20 Units Not Specified) (View Omeprazole Review and Omeprazole Label ), TAMSULOSIN HCL (1 Df=1 Units Not Specified) (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), DOCITON (1df-40 Units Not Mentioned Dociton 40) (View Dociton Review and Dociton Label ), ATACAND (1df- 16 Units Not Mentioned) (View Atacand Review and Atacand Label ), TORSEMIDE (1df-2.5 Units Not Mentioned) (View Torsemide Review and Torsemide Label ).

6704421-3 | Blood Creatine Phosphokinase Mb Increased, Myalgia
Patient was taking Baraclude (View Usage). Patient had the following side effects: blood creatine phosphokinase mb increased, myalgia on Apr 26, 2010 from CHINA Additional patient health information: Male patient , 50 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and. Baraclude dosage: . During the same period patient was treated with ESSENTIALE (View Essentiale Review and Essentiale Label ).